中国临床药理学杂志
中國臨床藥理學雜誌
중국림상약이학잡지
The Chinese Journal of Clinical Pharmacology
2015年
20期
2021-2023
,共3页
林纯婵%陈舒影%丁宇%李丹%张雪青%王良兴%余方友
林純嬋%陳舒影%丁宇%李丹%張雪青%王良興%餘方友
림순선%진서영%정우%리단%장설청%왕량흥%여방우
表皮葡萄球菌%莫匹罗星%耐药率
錶皮葡萄毬菌%莫匹囉星%耐藥率
표피포도구균%막필라성%내약솔
Staphylococcus epidermidis%mupirocin%resistance
目的:了解表皮葡萄球菌对莫匹罗星的耐药情况,并探讨其耐药菌株对临床常用抗菌药物的耐药特性。方法收集2012年到2014年分离的表皮葡萄球菌498株,对表皮葡萄球菌临床分离株进行菌种鉴定和药敏试验;用K-B法测定表皮葡萄球菌临床分离株对莫匹罗星的耐药性。结果498株表皮葡萄球菌中,39株对莫匹罗星耐药,耐药率为7.8%(39/498)。39株莫匹罗星耐药的表皮葡萄球菌均为耐甲氧西林表皮葡萄球菌( MRSE)。39株耐莫匹罗星的MRSE对奎诺普丁/达福普汀、利奈唑胺、万古霉素和呋喃妥因均表现为敏感,对青霉素、克林霉素、红霉素、环丙沙星和磺胺甲唑/甲氧苄啶等耐药率较高(>60%),对庆大霉素、利福平耐药率超过35%。结论莫匹罗星对表皮葡萄球菌表现出较好的体外抗菌活性,但对莫匹罗星耐药的表皮葡萄球菌已在临床分离株中出现,耐药性问题不容忽视。
目的:瞭解錶皮葡萄毬菌對莫匹囉星的耐藥情況,併探討其耐藥菌株對臨床常用抗菌藥物的耐藥特性。方法收集2012年到2014年分離的錶皮葡萄毬菌498株,對錶皮葡萄毬菌臨床分離株進行菌種鑒定和藥敏試驗;用K-B法測定錶皮葡萄毬菌臨床分離株對莫匹囉星的耐藥性。結果498株錶皮葡萄毬菌中,39株對莫匹囉星耐藥,耐藥率為7.8%(39/498)。39株莫匹囉星耐藥的錶皮葡萄毬菌均為耐甲氧西林錶皮葡萄毬菌( MRSE)。39株耐莫匹囉星的MRSE對奎諾普丁/達福普汀、利奈唑胺、萬古黴素和呋喃妥因均錶現為敏感,對青黴素、剋林黴素、紅黴素、環丙沙星和磺胺甲唑/甲氧芐啶等耐藥率較高(>60%),對慶大黴素、利福平耐藥率超過35%。結論莫匹囉星對錶皮葡萄毬菌錶現齣較好的體外抗菌活性,但對莫匹囉星耐藥的錶皮葡萄毬菌已在臨床分離株中齣現,耐藥性問題不容忽視。
목적:료해표피포도구균대막필라성적내약정황,병탐토기내약균주대림상상용항균약물적내약특성。방법수집2012년도2014년분리적표피포도구균498주,대표피포도구균림상분리주진행균충감정화약민시험;용K-B법측정표피포도구균림상분리주대막필라성적내약성。결과498주표피포도구균중,39주대막필라성내약,내약솔위7.8%(39/498)。39주막필라성내약적표피포도구균균위내갑양서림표피포도구균( MRSE)。39주내막필라성적MRSE대규낙보정/체복보정、리내서알、만고매소화부남타인균표현위민감,대청매소、극림매소、홍매소、배병사성화광알갑서/갑양변정등내약솔교고(>60%),대경대매소、리복평내약솔초과35%。결론막필라성대표피포도구균표현출교호적체외항균활성,단대막필라성내약적표피포도구균이재림상분리주중출현,내약성문제불용홀시。
Objective To investigate the resistance of Staphylococcus epidermidis isolates to mupirocin and its resistant characteristics to anti-bacterial agents used in clinical.Methods A total of 489 Staphyloco-ccus epidermidis isoliates were isolated from the various specimens of pa-tients in our Hospital.The identification and antimicrobial susceptibility testing of Staphylococcus epidermidis isolates were determined by Vitek-2 Compact full automated Microbiology Analyzer.The susceptibility of 489 Staphylococcus epidermidis isolates to mupirocin was determined by disc-diffusion method.Results Among 489 Staphylococcus epidermidis clini-cal isolates, 39 methicillin -resistant Staphylococcus epidermidis ( MRSE) were resistant to mupirocin.The prevalence of mupirocin resis-tance among Staphylococcus epidermidis clinical isolates was 7.8%(39/498).All mupirocin-resistant isolates were susceptible to quinu-pristin/dalfopristin, linezolid, vancomycin and nitrofurantoin. While more than 60%of mupirocin-resistant isolates were resistant to penici-llin, clindamycin, erythromycin and trimethoprim/sulfamethoxazole.The resistance rates of mupirocin -resistant isolates to gentamicin and rifapin were more than 35%. Conclusion Mupirocin is an effective agent against Staphylococcus epidermidis isolates in vitro.However, the mupiro-cin-resistant Staphylococcus epidermidis has appeared in clinical isolates which is of concern.